Apolioprotein Apo A1 Anti-Human Anti-body - Monoclonal

• High Purity Proteins
• Recombinant Proteins
• Antibodies
• Biologicals
• Fine Biochemicals
• Reagents

Item #: 125-12MAB

Details

Balb/C mice were immunized with highly purified human apoloipoprotein A-1.

The mouse spleen and lymph node lymphocytes were fused to firm hybridomas

Lee Biosolutions purified Mouse IgG1 kappa antibody was purified from tissue culture fluid using protein a chromatography. the monoclonal antibody reacts with human apolipoprotein A-1 by elisa and blotting applications.

Defects in APOA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) [MIM:604091]; also known as familial hypoalphalipoproteinemia (FHA). Inheritance is autosomal dominant.

Defects in APOA1 are the cause of amyloid polyneuropathy-nephropathy Iowa type (AMYLIOWA) [MIM:107680]; also known as amyloidosis van Allen type or familial amyloid polyneuropathy type III. AMYLIOWA is a hereditary generalized amyloidosis due to deposition of amyloid mainly constituted by apolipoprotein A1. The clinical picture is dominated by neuropathy in the early stages of the disease and nephropathy late in the course. Death is due in most cases to renal amyloidosis. Severe peptic ulcer disease can occurr in some and hearing loss is frequent. Cataracts is present in several, but vitreous opacities are not observed.

Defects in APOA1 are a cause of amyloidosis type 8 (AMYL8) [MIM:105200]; also known as systemic non-neuropathic amyloidosis or Ostertag-type amyloidosis. AMYL8 is a hereditary generalized amyloidosis due to deposition of apolipoprotein A1, fibrinogen and lysozyme amyloids. Viscera are particularly affected. There is no involvement of the nervous system. Clinical features include renal amyloidosis resulting in nephrotic syndrome, arterial hypertension, hepatosplenomegaly, cholestasis, petechial skin rash.

Popular Products